📅 2026 Update: Advances in Mesothelioma Treatment Options

Since the original article was written, there have been significant updates in mesothelioma treatment options. The U.S. Food and Drug Administration (FDA) approved new therapies that may improve survival rates for patients.

This section highlights the most important changes relevant to understanding mesothelioma treatment today. The earlier article continues further down the page, offering additional insights.

🧪 FDA Approvals of New Treatments

In September 2024, the FDA approved Keytruda® (pembrolizumab) as a first-line treatment for unresectable advanced or metastatic pleural mesothelioma. This approval was based on the KEYNOTE-483 clinical trial, which showed a median overall survival of 17.3 months for those receiving the drug in combination with chemotherapy.

💊 Combination Therapy Success

The FDA also approved the combination of Opdivo® (nivolumab) and Yervoy® (ipilimumab) for pleural mesothelioma in 2024. The CheckMate 743 trial indicated a median overall survival of 18.1 months, which is notable compared to 14.1 months for chemotherapy alone. This combination represents a significant advancement in treatment options.

🏥 Changes in Surgical Guidelines

According to the NCCN 2026 guidelines, pleurectomy/decortication (P/D) is now preferred over extrapleural pneumonectomy (EPP) for pleural mesothelioma. EPP is now only recommended for rare cases. The guidelines no longer suggest surgery for stages 2 through 4 of pleural mesothelioma.

💰 Updated Treatment Costs

As of October 2026, the average wholesale price for Keytruda® is about $10,000 per 100 mg vial. The costs for Opdivo® and Yervoy® are approximately $7,000 and $1,200 per vial respectively. These prices vary based on individual treatment plans and insurance coverage.

📈 Treatment Process Insights

Patients typically receive Keytruda® every three weeks through intravenous infusion. The treatment plan is tailored for each patient based on their specific health needs. The Opdivo® and Yervoy® combination involves an initial phase with both drugs, followed by maintenance with Opdivo® alone.

📌 Key Points Summary

  • 🧪 Keytruda® and Opdivo®/Yervoy® approved for mesothelioma.
  • 💊 Combination therapies show improved survival rates.
  • 🏥 NCCN guidelines favor P/D over EPP for surgery.
  • 💰 Current treatment costs vary based on individual plans.
  • 📈 Treatment processes are customized to patient needs.

💡 Tips for Understanding Mesothelioma Treatment Options

It's essential to review your specific situation with your attorney.

🩺 Understand Your Treatment Options

Familiarize yourself with the latest FDA-approved treatments. Keytruda® and the Opdivo® and Yervoy® combination are now important first-line options for pleural mesothelioma. Knowing these can help you make informed decisions.

📄 Review Clinical Trials

Consider discussing clinical trial participation with your healthcare provider. These trials often test new treatments that might not yet be widely available, providing access to innovative therapies.

🏥 Follow NCCN Guidelines

Stay updated on the NCCN guidelines for mesothelioma treatment. These guidelines are revised regularly and reflect the latest research and recommendations for surgical and non-surgical options.

💰 Check Treatment Costs

Be aware of the costs associated with new treatments. Understanding the average wholesale prices for Keytruda® and the Opdivo® and Yervoy® combination can help you plan financially.

📅 Ask About Eligibility Criteria

Discuss eligibility for new treatments with your healthcare provider. Factors like previous treatments and overall health can affect your options, so it’s essential to understand what applies to your case.

🔍 Seek Support Resources

Reach out to organizations like the Mesothelioma Applied Research Foundation or the National Cancer Institute for additional information and resources. They can provide guidance on treatment options and support services.

🏆 Free Options Ranked by User Reviews (2026)

No national paid service in this area met the review threshold, so this section lists free government and nonprofit resources available for mesothelioma treatment support.

🥇 1. Mesothelioma Applied Research Foundation

This nonprofit organization offers resources and support for mesothelioma patients. They provide valuable information on treatment options and access to clinical trials. Their mission is to improve the lives of those affected by mesothelioma through research and education.

🥈 2. National Cancer Institute (NCI)

The NCI provides comprehensive information on mesothelioma, including treatment options and clinical trials. They also offer support resources for patients and families, helping them navigate their diagnosis and treatment journey.

🥉 3. American Cancer Society

The American Cancer Society offers information on cancer treatments and support services. They provide resources for mesothelioma patients, including guidance on treatment options and emotional support.

4️⃣ CancerCare

CancerCare offers free support services for cancer patients, including those with mesothelioma. They provide counseling, support groups, and financial assistance resources, helping patients cope with the challenges of their diagnosis.

5️⃣ Patient Advocate Foundation

This organization helps patients navigate healthcare access and insurance issues. They offer case management services for mesothelioma patients to ensure they receive the care they need without facing financial barriers.

🔎 What to Check Before Paying for Help

  • 💵 Investigate the cost structure of services.
  • 📄 Verify the organization’s credibility and mission.
  • 📞 Look for testimonials or reviews from other users.
  • 📊 Confirm if the service is nonprofit and free of charge.
  • 🔍 Ensure they provide clear information on treatment options.

❓ Frequently Asked Questions

🤔 What is the survival rate for mesothelioma with new treatments?

Recent approvals, such as Keytruda® and the Opdivo® and Yervoy® combination, have shown median overall survival rates of 17.3 months and 18.1 months, respectively. These new options may provide better outcomes than previous treatments.

🧬 How do I know if I qualify for Keytruda®?

Eligibility for Keytruda® is determined by your oncologist. It is typically for patients with unresectable advanced or metastatic pleural mesothelioma who have not received prior systemic therapy.

📅 What are the latest guidelines for surgical treatments?

The NCCN 2026 guidelines now recommend pleurectomy/decortication (P/D) over extrapleural pneumonectomy (EPP) for most patients. EPP is reserved for rare cases and is no longer recommended for later-stage mesothelioma.

💊 Are there any immunotherapy options?

Yes, immunotherapy is an important focus in mesothelioma treatment. Keytruda® and the Opdivo® and Yervoy® combination are notable immunotherapy options that have shown promising results in extending survival.

🏥 How often do patients receive Keytruda®?

Patients typically receive Keytruda® through an intravenous infusion every three weeks. The treatment plan is individualized based on each patient's health status.

🔬 Can I participate in a clinical trial?

Yes, clinical trials are available for mesothelioma patients. Discuss potential participation with your healthcare provider to learn about current trials that may be suitable for your condition.

⚖️ Recent Court Rulings on Mesothelioma Cases

Recent court rulings have impacted how mesothelioma cases are handled, especially concerning claims and compensation for victims. These rulings often shape treatment options and rights for patients and their families.

For the latest updates, you can browse more rulings on the news page.

End of October 2026 Update






 



Mesothelioma Prognosis



Unfortunately, mesothelioma is among the various diseases that continues to produce quite a disappointing and negative prognosis. To this day, there is no known or medically-accepted cure for mesothelioma. If you need legal advice and assistance, contact mesothelioma lawyers.

However, even though it is extremely rare, there have been cases where the disease has been cured without remission. Also, advancements in the treatment for mesothelioma have significantly improved the overall life expectancy in mesothelioma patients.

Determining mesothelioma treatment options, there are various factors that must be considered. Among aspects to be considered, the most common are:

• Stage of mesothelioma – The earlier that the disease is diagnosed, the better chance the patient will have of survival.

• Patient’s age

• Overall health status – If the disease has progressed to the extent that the health is considered to be poor, the mesothelioma treatment options will prove to be limited for some may be too dangerous to consider.

• Type of mesothelioma – Depending on where the cancer is situated will dictate the overall type of treatment that can be administered.

Understanding Mesothelioma Treatment Options


Surgery



Surgery is often the first type of mesothelioma treatment option that is considered. However, the overall success of surgery, when undertaken alone, is not very successful. Patients that will undergo surgery and not undertake other mesothelioma treatment options will usually have a life expectancy of less than one year.

When surgery is combined with the other existing mesothelioma treatment options, namely radiation and chemotherapy, there may be greater rates of success, even though results still prove to vary.

The most common types of surgery that are used for mesothelioma treatment options are:

• Pleurectomy/Decortication – Entails the actual removal of the chest cavity’s inner lining; this is the most common type of surgery for mesothelioma patients.

• Extrapleural Pneumonectomy – Involves removing various internal organs of the patient, which can include:

• Part of the lung

• Lining of the lung

• Lining of the chest cavity

• Hemi-diaphragm

• Pericardium



Radiation



Radiation is often times given to patients after mesothelioma surgery to help further combat the disease. Typically, patients that have the cancer localized and are physically fit to withstand radiation treatment will be candidates for this kind of mesothelioma treatment.

Radiation will usually also be accompanied with chemotherapy as well, for mesothelioma tumors seem to be quite resistant to radiation therapy alone. Radiation alone has proven to be ineffective in treating the cancer and the necessary amount of radiation needed to have any kind of effect is toxic to the human body.

Radiation is usually done with the intention of preventing issues of remission and preventing the cancer from further spreading along the chest wall and other internal organs. When used in conjunction with chemotherapy as a post-operative treatment option, patient life expectancy is often more than five years.



Chemotherapy



Though other mesothelioma treatment options exist, the most effective has proven to be chemotherapy. The effectiveness of chemotherapy is further enhanced when used in combination with radiation after mesothelioma surgery.

In various trials, chemotherapy drugs such as cisplatin and pemetrexed have been used as the sole treatment for patients with pleural mesothelioma, which rendered various results. However, there were general improvements in using chemotherapy alone, extended life expectancy to over 13 months as opposed to the 10 month median.